MOR1K	O
expression	O
and	O
binding	O
pattern	O
.	O

(	O
A	O
)	O
The	O
schematic	O
diagram	O
illustrates	O
the	O
exonic	O
composition	O
and	O
relative	O
positions	O
of	O
PCR	O
primers	O
designed	O
to	O
amplify	O
the	O
major	O
MOR1	O
isoform	O
and	O
the	O
newly	O
identified	O
alternative	O
MOR1K	O
isoform	O
.	O

The	O
relative	O
positions	O
of	O
translation	O
initiation	O
start	O
and	O
stop	O
codons	O
are	O
designated	O
by	O
ATG	O
and	O
TGA	O
,	O
respectively	O
.	O

The	O
predicted	O
protein	O
structure	O
of	O
MOR1	O
and	O
MOR1K	O
isoforms	O
is	O
schematically	O
presented	O
.	O

Translation	O
of	O
the	O
MOR1K	O
variant	O
results	O
in	O
a	O
6TM	O
receptor	O
,	O
truncated	O
at	O
the	O
N	O
-	O
terminus	O
.	O

(	O
B	O
)	O
Real	O
-	O
time	O
PCR	O
was	O
performed	O
on	O
total	O
RNA	O
samples	O
from	O
the	O
human	O
brain	B-Multi-tissue_structure
regions	I-Multi-tissue_structure
known	O
to	O
express	O
MOR1	O
.	O

Primers	O
specific	O
for	O
exons	O
1	O
and	O
2	O
were	O
used	O
to	O
measure	O
MOR1	O
and	O
primers	O
specific	O
for	O
exons	O
13	O
and	O
exon	O
2	O
were	O
used	O
to	O
measure	O
MOR1K	O
[	O
32	O
]	O
.	O

GAP3DH	O
was	O
used	O
as	O
a	O
control	O
for	O
cDNA	O
loading	O
and	O
PCR	O
efficiency	O
.	O

(	O
C	O
)	O
Confocal	O
images	O
of	O
C	O
-	O
terminally	O
MYC	O
-	O
tagged	O
MOR1	O
or	O
FLAG	O
-	O
tagged	O
MOR1K	O
overexpressed	O
in	O
HEK293	B-Cell
cells	I-Cell
and	O
stained	O
with	O
either	O
Anti	O
-	O
MYC	O
-	O
Tag	O
Antibody	O
(	O
Alexa	O
Fluor	O
647	O
Conjugate	O
)	O
or	O
Anti	O
-	O
DYKDDDDK	O
Tag	O
Antibody	O
(	O
Alexa	O
Fluor	O
555	O
conjugate	O
)	O
.	O

Cells	B-Cell
transfected	O
with	O
MOR1	O
showed	O
membrane	B-Cellular_component
expression	O
of	O
receptor	O
,	O
while	O
cell	B-Cell
transfected	O
with	O
MOR1K	O
express	O
receptor	O
only	O
intracellular	B-Immaterial_anatomical_entity
.	O

(	O
D	O
)	O
Confocal	O
images	O
of	O
C	O
-	O
terminally	O
FLAG	O
-	O
tagged	O
MOR1K	O
overexpressed	O
in	O
Be2C	B-Cell
cells	I-Cell
and	O
stained	O
with	O
either	O
Anti	O
-	O
FLAG	O
M2	O
Antibody	O
Alexa	O
Fluor	O
Conjugate	O
or	O
fluorescent	O
-	O
labeled	O
naloxone	O
(	O
FNAL	O
)	O
.	O

Cells	B-Cell
transfected	O
with	O
MOR1K	O
showed	O
intracellular	B-Immaterial_anatomical_entity
retention	O
of	O
FNAL	O
that	O
co	O
-	O
localized	O
with	O
antibody	O
-	O
labeled	O
receptor	O
.	O

(	O
E	O
)	O
The	O
binding	O
of	O
naloxone	O
to	O
MOR1K	O
was	O
assessed	O
using	O
flow	O
cytometry	O
to	O
measure	O
FNAL	O
retention	O
.	O

Be2C	B-Cell
cells	I-Cell
transfected	O
with	O
either	O
MOR1	O
or	O
MOR1K	O
isoforms	O
showed	O
increased	O
retention	O
of	O
FNAL	O
at	O
concentrations	O
of	O
0	O
.	O
1	O
and	O
1	O
muM	O
.	O

FNAL	O
retention	O
was	O
abolished	O
in	O
the	O
presence	O
of	O
10	O
muM	O
unlabelled	O
naloxone	O
(	O
Nal	O
)	O
.	O

In	O
panel	O
E	O
,	O
data	O
are	O
presented	O
as	O
mean	O
+	O
SEM	O
.	O

*	O
P	O
<	O
0	O
.	O
05	O
different	O
from	O
controls	O
)	O
.	O

